TrialJournal of affective disorders2018

Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting.

Mark Sinyor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.